Appointments

VaxGen hires former consultant to head business development

Published in Vaccine Weekly, August 21st, 2002

VaxGen, Inc., (XGN) announced that Piers Whitehead, a widely recognized consultant and advisor to the pharmaceutical and vaccine industry, has joined the company as vice president, corporate and business development.

Whitehead previously served as a senior executive with Mercer Management Consulting, where he led a series of marketing, strategy, and manufacturing projects with an emphasis on global health and vaccines.

"Piers' reports on the state of international vaccine development, including the analysis of manufacturing economics for the developing world, have become standard references for the field," said Lance K. Gordon, PhD, CEO of VaxGen. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry